Effect of Evacetrapib on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 09 Oct 2018
Price : $35 *
At a glance
- Drugs Evacetrapib (Primary) ; Warfarin
- Indications Atherosclerosis; Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 12 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 18 Jun 2014 New trial record